CA
NZ
UK
AU
IND
US
Recorlev, a treatment for Cushing's syndrome, generated USD 71.5 million, up 93%, and is now the main growth engine. Gvoke, the ready-to-use glucagon, fell 14% to USD 21.7 million, a decline that included a one-time gross-to-net adjustment of about USD 4 million, which is …
Profit grew much faster than revenue because the sales mix moved toward ASCENIV, which commands higher pricing, while BIVIGAM, an older immune globulin, fell 35% to USD 15.4 million. Adjusted EBITDA, which excludes interest, taxes,Depreciationand certain non-cash items, is the figure management uses to …
Baird Medical describes itself as a medical device company focused on minimally invasive microwave ablation. Its lead system is cleared by the United States Food and Drug Administration for soft tissue ablation and is being introduced in the United States mainly for benign thyroid …
Operating metrics were solid. Comparable RevPAR of USD 284 was the second-highest third-quarter figure in company history, and comparable Hotel EBITDAMarginwidened 122 basis points to 13.6%. Urban properties saw RevPAR climb 23.3% and Hotel EBITDA rise 63.2% to USD 10.1 million. Resort properties lifted …
The filing explains that on March 27, 2026 the US Court of Appeals for the Second Circuit reversed the judgment in favor of Petersen and Eton Park in the YPF-related assets, and theBalance SheetFair Valueof thoseAssetswas significantly reduced. Capital provision assets fell to USD …
Net sales were USD 656.4 million, up 0.5% or about 0.7% on a currency-neutral basis. Clinical Diagnostics sales rose 2.7% to USD 401.8 million on quality systems and diabetes products, while Life Science sales fell 2.8% to USD 254.6 million on lower process chromatography …
Over nine months, net investment income was USD 2.20 per share against USD 2.43, and net realized and unrealized losses of USD 1.55 per share more than offset it after distributions of USD 2.31 per share. Net asset value per share fell to USD …
The PeopleReady unit, which supplies on-demand and skilled trade labor, produced USD 338.0 million of revenue against USD 251.4 million a year earlier, an increase of about 34% on simple arithmetic and the main driver of the quarter. Staffing firms have high operating leverage: …
The key variable for a buy now pay later lender is credit cost. Provision for credit losses was USD 37.7 million, or 2.7% of transaction value against 3.1%, and transaction related costs fell to 4.2% from 5.2%. Management now guides to 2026 revenue growth …
Volume growth was modest. Admissions were 41,899, up 0.1%, while adjusted admissions, which blend inpatient and outpatient activity, rose 2.9% to 91,933.Capital Expenditureguidance was trimmed to USD 210 million to USD 250 million from USD 225 million to USD 265 million, which supports free …
Please wait processing your request...